Raiffeisen Bank International’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4M Buy
289,788
+1,333
+0.5% +$112K 0.31% 76
2026
Q1
$22.9M Sell
288,455
-21,662
-7% -$1.79M 0.33% 79
2025
Q4
$26.7M Buy
310,117
+220
+0.1% +$18.1K 0.34% 79
2025
Q3
$23.9M Buy
309,897
+9,622
+3% +$752K 0.32% 81
2025
Q2
$23.1M Sell
300,275
-369
-0.1% -$27.5K 0.34% 82
2025
Q1
$21.3M Sell
300,644
-20,691
-6% -$1.48M 0.34% 85
2024
Q4
$23.9M Buy
+321,335
New +$22.5M 0.36% 77

Other funds holding EW

Raiffeisen Bank International's EW Position: Q2 2026 in Review

Raiffeisen Bank International increased its Edwards Lifesciences (EW) stake by 0.46% in Q2 2026, buying an estimated $112K and bringing the position to 289,788 shares worth $26.4M. The position accounts for 0.31% of the portfolio, ranked #76.

Raiffeisen Bank International first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.7M in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Raiffeisen Bank International held 289,788 shares of Edwards Lifesciences worth $26.4M as of Q2 2026.
  • Raiffeisen Bank International bought 1,333 Edwards Lifesciences shares in Q2 2026, an estimated $112K.
  • Edwards Lifesciences made up 0.31% of Raiffeisen Bank International's portfolio in Q2 2026, its #76 holding.
  • Raiffeisen Bank International first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Edwards Lifesciences position peaked at $26.7M in Q4 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.